Delivery Order SPE2DB20D3303-SPE2DB25FA2TX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.80 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract, executed on November 19, 2024, with an ultimate completion date of November 20, 2024, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,060.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a $2,014.32 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,014.32 to AmerisourceBergen Drug Corp for the provision of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a $5,035.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 12, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's existing federal contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,659.15 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5 mL, a meningococcal vaccine. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $3,357.20 delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W vaccine kits (2 vials) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under AmerisourceBergen's broader federal...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2TXDelivery Order
The Defense Logistics Agency awarded a $3,357.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials), with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a pediatric meningococcal vaccine delivery under the company's existing pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The award reflects AmerisourceBergen Drug Corp's proven capability to fulfill federal medical supply requirements through competitive procurement processes and its role as a key vendor within DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/19/25 |